CVOTs In response to FDA guidelines requiring the assessment of anti-diabetic therapeutics in relation to cardiovascular risk, several CVOTs have been performed
Retatrutide is a synthetic peptide developed by the same company behind Mounjaro (tirzepatide)
For anecdotal human evidence, high-profile users like Andrew Huberman have reported using BPC-157 for vertebral compression pain with positive results
Many nephrologists are now studying whether GLP-1 medications can: Slow kidney disease progression Reduce inflammation Improve blood sugar control Lower cardiovascular risks Help patients qualify for kidney transplant eligibility through weight loss For some patients, losing excess weight may also improve mobility, blood pressure, and overall quality of life while on dialysis
Pyrazolopyrimidine, another similar aromatic core structure, forms - interactions with the phenyl substituent of Phe357
A Clinic Answer Injected peptides carry almost no calories, so in the caloric sense they generally do not break a fast